(Q44555874)

4 December 2017

title

Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC). (English)

1 reference

non-small-cell lung carcinoma

4 December 2017

main subject

1 reference

Domenico Ferrigno

1

1 reference

4 December 2017

Gianfranco Buccheri

series ordinal

2

1 reference

4 December 2017

Cristina Giordano

series ordinal

3

1 reference

4 December 2017

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

41

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

311-320

1 reference

4 December 2017

cites work

Tumor markers. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Clinical applications of serum markers for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Serum tumour markers in lung cancer: history, biology and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Prognostic factors in lung cancer: tables and comments

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Primer on certain elements of medical decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Clinical significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Prognostic value of the tissue polypeptide antigen in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

The tissue polypeptide antigen serum test in the preoperative evaluation of non-small cell lung cancer. Diagnostic yield and comparison with conventional staging methods

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Neuron-specific enolase as a guide to the treatment of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Value of serum neuron-specific enolase in nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Expression of peptide and other markers in lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Peptide hormone production in primary lung tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

Ectopic (Inappropriate) Hormone Production by Tumors: Mechanisms Involved and the Biological and Clinical Implications*

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900232-0

7 January 2021

10.1016/S0169-5002(03)00232-0

Identifiers

DOI

1 reference

4 December 2017

1 reference